Valens Semiconductor (VLN) SVP exercises options and sells 400 shares

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Valens Semiconductor SVP, R&D Chairman David reported an options exercise paired with a small open-market sale of ordinary shares. On April 22, 2026, he exercised stock options for 400 ordinary shares at $0.86 per share and sold 400 shares at $1.65 per share on the same day.

The filing notes these sales were made under a Rule 10b5-1 trading plan adopted on August 16, 2024, indicating they were pre-planned. After the transactions, he directly holds 403,968 ordinary shares and 91,295 stock options, so the net share sale is small relative to his overall position.

Insider Trade Summary 10b5-1

Net Seller: 400 shares ($660)

Net Sell 3 txns

Insider Chairman David

Role SVP, R&D

Sold 400 shs ($660.00)

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	400	$0.00	--
Exercise	Ordinary Shares	400	$0.86	$344.00
Sale	Ordinary Shares	400	$1.65	$660.00

Holdings After Transaction: Stock Option (Right to Buy) — 91,295 shares (Direct, null); Ordinary Shares — 404,368 shares (Direct, null)

Footnotes (1)

The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024 The shares were acquired upon the exercise of stock options The shares sold were acquired upon the exercise of stock options on the same date The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.

Key Figures

Shares sold: 400 shares at $1.65 Options exercised: 400 shares at $0.86 Shares owned after: 403,968 shares +3 more

6 metrics

Shares sold 400 shares at $1.65 Open-market sale on April 22, 2026

Options exercised 400 shares at $0.86 Stock option exercise on April 22, 2026

Shares owned after 403,968 shares Direct ownership following transactions

Options remaining 91,295 options Stock options after exercise on April 22, 2026

Option expiration June 9, 2031 Expiration date of exercised stock options

10b5-1 plan adoption August 16, 2024 Date trading plan for sales was adopted

Key Terms

Rule 10b5-1 trading plan, Stock Option (Right to Buy), open-market sale, derivative exercise/conversion

4 terms

Rule 10b5-1 trading plan regulatory

"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

derivative exercise/conversion financial

"transaction_action: derivative exercise/conversion"

Form 4 Insider Transactions: What Each Field Means →

04/23/2026 - 08:38 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chairman David

(Last)

(First)

(Middle)

42 HOLOT GEULIM

(Street)

ZORAN

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Valens Semiconductor Ltd. [ VLN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, R&D

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	04/22/2026		M⁽¹⁾		400⁽²⁾	A	$0.86	404,368	D
Ordinary Shares	04/22/2026		S⁽¹⁾		400⁽³⁾	D	$1.65	403,968	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$0.86	04/22/2026		M⁽⁴⁾			400	06/01/2022	06/09/2031	Ordinary Shares	400	$0	91,295	D

Explanation of Responses:

1. The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024

2. The shares were acquired upon the exercise of stock options

3. The shares sold were acquired upon the exercise of stock options on the same date

4. The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.

	David Chairman by: Oppenheimer Israel, as Attorney-in-fact	04/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Valens Semiconductor (VLN) report for its SVP, R&D?

Valens Semiconductor’s SVP, R&D Chairman David exercised options for 400 ordinary shares at $0.86 and sold 400 shares at $1.65. The exercise-and-sell occurred on April 22, 2026, as a combined transaction reported in the Form 4 filing.

How many Valens Semiconductor (VLN) shares did the insider sell and at what price?

Chairman David sold 400 Valens Semiconductor ordinary shares at $1.65 per share. These shares had been acquired the same day through a stock option exercise and were sold as part of a pre-planned Rule 10b5-1 trading arrangement.

What stock options did the Valens Semiconductor (VLN) insider exercise?

The insider exercised stock options covering 400 ordinary shares with a $0.86 exercise price. These options were originally exercisable from June 1, 2022, and were set to expire on June 9, 2031, before being exercised and immediately sold as common shares.

How many Valens Semiconductor (VLN) shares does the insider hold after the Form 4 transactions?

Following the reported transactions, Chairman David directly owns 403,968 ordinary shares of Valens Semiconductor. He also holds 91,295 stock options, providing additional potential equity exposure beyond his existing common share ownership position.

Were the Valens Semiconductor (VLN) insider sales discretionary or under a 10b5-1 plan?

The sales were made under a Rule 10b5-1 trading plan adopted on August 16, 2024. Such plans schedule trades in advance, indicating the timing of these 400-share sales was pre-arranged rather than a spontaneous market-timing decision.